Clinical Trial Update: Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis [NA]

View source ↗

Summary

This trial evaluated how micronized fenofibrate influences fasting and postprandial lipoproteins, inflammatory mediators, and thrombosis. Participants had hyper…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia with the Metabolic Syndrome

Drugs mentioned

• Fenofibrate (micronized) (fenofibrate)

Snippet

Sponsor: University of Michigan | Conditions: Hypertriglyceridemia With the Metabolic Syndrome | NA | Status: COMPLETED